Inhibition of p38 Mitogen-Activated Protein Kinase Blocks Activation of Rat Pancreatic Stellate Cells
Authors:
- Atsushi MasamuneAMAtsushi Masamune
- Masahiro SatohMSMasahiro Satoh
- Kazuhiro KikutaKKKazuhiro Kikuta
- Yoshitaka SakaiYSYoshitaka Sakai
- Akihiko SatohASAkihiko Satoh
- Tooru ShimosegawaTSTooru Shimosegawa
- 1 January 2003
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 304 (1) , 8-14
Abstract
Activated pancreatic stellate cells (PSCs) have recently been implicated in the pathogenesis of pancreatic fibrosis and inflammation. However, the signal transduction pathways in PSCs remain largely unknown. We examined the role of p38 mitogen-activated protein (MAP) kinase in the activation of PSCs. PSCs were isolated from rat pancreas tissue and used in their culture-activated, myofibroblast-like phenotype. Activation of p38 MAP kinase was determined by Western blotting using anti-phosphospecific antibody. The effects of two p38 MAP kinase inhibitors, 4-(4-flurophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)imidazole (SB203580) and 4-(4-flurophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole (SB202190), on the parameters of PSC activation, including proliferation, expression of α-smooth muscle actin, α1(I) procollagen, and prolyl 4-hydroxylase (α) genes, and monocyte chemoattractant protein-1 production were evaluated. Interleukin-1β and platelet-derived growth factor-BB activated p38 MAP kinase. Platelet-derived growth factor-induced PSC proliferation was inhibited by SB203580 and SB202190. These reagents decreased α-smooth muscle actin protein expression, and α1(I) procollagen and prolyl 4-hydroxylase (α) mRNA levels. Treatment with these p38 MAP kinase inhibitors also resulted in inhibition of monocyte chemoattractant protein-1 expression. In addition, SB203580 inhibited spontaneous activation of freshly isolated PSCs in culture on plastic. Thus, inhibition of p38 MAP kinase modulated profibrogenic and proinflammatory actions in PSCs, implying a potential application of p38 MAP kinase inhibitors for the treatment of pancreatic fibrosis and inflammation.Keywords
This publication has 42 references indexed in Scilit:
- Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblastsGastroenterology, 2000
- Induction of Smooth Muscle α-Actin in Vascular Smooth Muscle Cells by Arginine Vasopressin Is Mediated by c-Jun Amino-terminal Kinases and p38 Mitogen-activated Protein KinaseJournal of Biological Chemistry, 2000
- AKT/PKB and Other D3 Phosphoinositide-Regulated Kinases: Kinase Activation by Phosphoinositide-Dependent PhosphorylationAnnual Review of Biochemistry, 1999
- Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesisGut, 1999
- Identification, culture, and characterization of pancreatic stellate cells in rats and humansGastroenterology, 1998
- Periacinar stellate shaped cells in rat pancreas: identification, isolation, and cultureGut, 1998
- IκBα Degradation and Nuclear Factor-κB DNA Binding Are Insufficient for Interleukin-1β and Tumor Necrosis Factor-α-induced κB-dependent TranscriptionJournal of Biological Chemistry, 1998
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1FEBS Letters, 1995
- Signals and Receptors Involved in Recruitment of Inflammatory CellsJournal of Biological Chemistry, 1995
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993